Cargando…
Proteinuria in systemic sclerosis: reversal by ACE inhibition
In systemic sclerosis (SSc), kidney damage is a major clinical problem which can lead to a deleterious outcome. Recently, in diabetes mellitus, early detection of proteinuria and treatment with angiotensin-converting enzyme (ACE) inhibitors has been shown to slow progression of kidney disease and to...
Autores principales: | Schuster, J., Moinzadeh, P., Kurschat, C., Benzing, T., Krieg, T., Weber, M., Hunzelmann, N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3751210/ https://www.ncbi.nlm.nih.gov/pubmed/23446441 http://dx.doi.org/10.1007/s00296-013-2691-6 |
Ejemplares similares
-
Pharmacology and rationale for imatinib in the treatment of scleroderma
por: Moinzadeh, Pia, et al.
Publicado: (2013) -
Pathophysiological Mechanisms in Sclerosing Skin Diseases
por: Eckes, Beate, et al.
Publicado: (2017) -
High frequency of corticosteroid and immunosuppressive therapy in patients with systemic sclerosis despite limited evidence for efficacy
por: Hunzelmann, Nicolas, et al.
Publicado: (2009) -
Additive effects of intensive BP control and ACE inhibition on suppression of proteinuria in patients with CKD
por: Lopez, Rafael, et al.
Publicado: (2023) -
ACE Inhibition in Anti-Thy1 Glomerulonephritis Limits Proteinuria but Does Not Improve Renal Function and Structural Remodeling
por: Westerweel, Peter E., et al.
Publicado: (2012)